Mutual Recognition Agreements (MRAs) are agreements between two trading partners on the elimination of technical barriers to trade. This is one of the issues that will be important in the trade negotiations between the UK and the EU. This leaves “traditional” conformity assessment MRAs as the only viable option, which means higher costs for exporters, as they may have to manufacture goods to two sets of standards (UK and EU) and have their goods tested in the UK before they can be exported to the EU. For the purposes of this sectoral chapter, `conformity assessment bodies` also means the authorities responsible for calibration (80 KB) (testing services and laboratories). However, recent free trade agreements indicate a shift in approach and acceptance of “traditional” RAs. According to the Cassis de Dijon principle, a product that can be legally sold in one Member State, even if the rules are not harmonised, can be legally sold in any other Member State. During a transition period, the authorities will mutually assess pharmaceutical legislation, guidance and regulatory systems under the agreement. The UK document reaffirms the importance of regulatory autonomy – “protecting each party`s right to regulation” – but also builds on earlier considerations by suggesting that the agreement “should create a framework for each party to require the other party to consider its technical regulation equivalent to its own regulation”. The MRA with Israel is an agreement on the compliant evaluation and acceptance of industrial products (ACAA). This is a specific type of MRA based on the alignment of the legal system and infrastructure of the country concerned with that of the EU. For example, the European Commission`s recently concluded free trade agreements with Canada and Korea provide for the conclusion of MRAs for conformity assessment without their partners being asked to align their regulatory requirements with those of the EU. The EU-Australia Agreement covers the following sectors For the purposes of this Sectoral Chapter, `conformity assessment bodies` means testing facilities recognised under each Party`s GLP monitoring programme. By granting mutual recognition to products covered by free trade agreements with Canada and Korea, but refusing to treat products originating in the UK on an equal footing, the EU could be violating WTO law.
This would make life much more difficult for British manufacturers, as they would be forced to have products certified by EU authorities before they could export them to the continent. The European Commission`s approach to the UK`s ripper is different from the one it has negotiated with other countries. Fundamentally, “traditional” MRAs do not require states to harmonize rules (i.e., .